Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
The tissue microenvironment in prostate cancer is profoundly altered. How prostate cancer cells and their precursors mediate those changes is unclear, in part due to the inability to longitudinally study the disease evolution in human tissues. To overcome this limitation, we performed extensive single-cell RNA-sequencing (scRNA-seq) to assess the transcriptional profiles of the tissue microenvironment in prostate tissues from prostatectomies from men diagnosed with prostate cancer. For each subject, benign-enriched and tumor-enriched tissues were collected from the peripheral zone of the prostate. Our studies of human tissues revealed that cancer cell-intrinsic activation of MYC signaling was the top up-regulated pathway in human cancers, representing a common denominator across the well-known molecular and pathological heterogeneity of human prostate cancer. Numerous non-malignant cell states in the tumor microenvironment (TME), including non-cancerous epithelial, immune, and fibroblast cell compartments, were conserved across individuals, suggesting that these cell types may be a sequelae of the convergent MYC activation in the cancer cells.
- Study Weblinks:
- Study Design:
- Tumor vs. Matched-Normal
- Study Type:
- Single Cell Analysis
- Total number of consented subjects: 7
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Study Inclusion/Exclusion Criteria
Men diagnosed with primary prostate cancer with no prior treatment who underwent prostatectomy.
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Prostatic Neoplasms
- Tumor Microenvironment
- Links to Related Genes
- Authorized Data Access Requests
-
See research articles citing use of the data from this study
- Study Attribution
-
-
Principal Investigator
- Srinivasan Yegnasubramanian. Johns Hopkins University, Baltimore, MD, USA.
-
Co-Investigator
- Angelo De Marzo. Johns Hopkins University, Baltimore, MD, USA.
-
Sequencing Center
- Sidney Kimmel Comprehensive Cancer Center Experimental and Computational Genomics Core. Johns Hopkins University, Baltimore, MD, USA.
-
First Author
- Mindy Kim Graham. Northwestern University, Chicago, IL, USA.
-
Principal Investigator